drugset / Trial / NCT01333397
Safety and Efficacy Study of Dysport RU and Glabellar Lines
RandomizedParallel-groupTriple-blindTreatment
Summary
The primary objective is to assess the dose response versus placebo of a single treatment of Dysport RU (Dysport RU, Ready to Use, for injection), for the improvement in appearance of moderate to severe glabellar lines at maximum frown.
Timeline
- Start
- 2011-03
- Primary completion
- 2011-09
- Completion
- 2011-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Botulinum toxin type A | Protein / enzyme biologic | 20 iu | Intramuscular |
| Comparator | Botulinum toxin type A | Protein / enzyme biologic | 50 iu | Intramuscular |
| Comparator | Botulinum toxin type A | Protein / enzyme biologic | 75 iu | Intramuscular |
Indications
No indication recorded.